euro adhoc: Leonardo Venture GmbH & Co. KGaA / Financial Figures/Balance Sheet / Leonardo Venture publishes figures for second and third quarter of 2008

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

quaterly report

15.12.2008

• Review of all values in the portfolio concluded • Investments in
NanoCompound Holding AG and Rösler miniDaT GmbH written down in full
• Amortization also at VRmagic Holding and MedicalCommunications GmbH
• New valuation of investments leads to considerable loss for 2008

Leonardo Venture GmbH & Co. KGaA has concluded the review of the
entire investment portfolio as publicized in the ad hoc announcement
from November 19, 2008 and is now publishing the belated interim
reports for the second and third quarters of 2008.

In addition to the complete write-down of the portfolio companies
NanoCompound Holding AG and Rösler miniDaT GmbH with a total volume
of EUR 10.7 million, which had already been announced, additional
amortization was performed. This concerns the investments in VRmagic
Holding AG and MedicalCommunications Soft- und Hardware GmbH, whose
values were reduced by EUR 4.4 million and EUR 2.2 million,
respectively.

The main reason for the amortization of NanoCompound Holding AG lies
in massive problems in the business development, which have led to
the liquidity being exhausted. In the case of Rösler miniDaT GmbH the
review of the investment revealed that it does not have the
corresponding recoverable value as a pure sales company. The cause of
the impairment at VRmagic Holding AG is an unrealistic company
valuation prepared in the framework of the company´s growth strategy.
Unviable growth financing had been imputed in the underlying expert
opinions for the valuation. On the whole, however, the profitable
company has displayed a positive business development that promises
further growth potential for the future. The devaluation of the fair
value merely reduces to a realistic level the earlier excessive
expectations placed on the future corporate development. At
MedicalCommunications a sale to a strategic investor in the framework
of an asset deal was prepared in the current 2008 fiscal year; this
sale did not materialize, however. A lack of resources in the area of
marketing and sales led to a downturn in revenues in 2008, something
which triggered an amendment of the fair value. Leonardo Venture GmbH
& Co. KGaA is currently conducting talks with the management of the
company on possible growth financing so that MedicalCommunications
may attain a considerable increase in revenues with highly
competitive products.

The remaining investments of Leonardo Venture GmbH & Co. KGaA
continue to be valued at continued acquisition costs to IFRS as of
the end of the third quarter of 2008. The operational development of
these is going according to plan, with some companies displaying an
above-average growth potential.

On the whole the result from the new valuation of financial assets
(investments) to IFRS as of the end of the third quarter of 2008 is
EUR -17.4 million (previous year: EUR 0.3 m). Taking into
consideration the other operating income and expenses, the ordinary
operating result for the first nine months of 2008 is EUR -19.2
million compared to EUR -1.2 million in the same period of the
previous year. The financial result of EUR 0.7 million is a
considerable improvement over the previous year (EUR 0.4 m) as the
hidden reserves in the portfolio companies have yielded appropriate
interest and interest income was attained from the sums paid in
following the capital increase. The result from ordinary activities
is EUR -18.5 million compared to EUR -0.8 million in the first nine
months of 2007. After the deduction of taxes, the loss to IFRS for
the period January 1 to September 30, 2008 is EUR 18.7 million
(previous year: EUR 1.1 m). This corresponds to a result of EUR -1.10
per share. In the current fiscal year no exits were realized in the
portfolio, also due to the weak IPO and M&A market environment.

Leonardo Venture is still on a solid financial footing. The liquid
funds as of the cut-off date at the end of September 2008 were EUR
14.8 million (December 31, 2007: EUR 18.5 million). As Leonardo
Venture still does not have any long-term liabilities, the equity
capital ratio at the end of the third quarter of 2008 is 97.5
percent.

The Supervisory Board and management intend to put the investment
business of Leonardo Venture back on course in the 2009 fiscal year
and to strategically re-orient the company. Against the background of
the current favorable entry valuations with young growth companies,
new and promising investment options are constantly being examined.
To this end the investment advisory council is being consolidated.
The Supervisory Board and management have already acquired a new
member of this council in Prof. Dr. Manfred Gröger. Prof. Gröger is
active as a professor for accounting and project management. At the
annual general meeting planned for February 2009 the Supervisory
Board and management will present the future strategy of the company.

About Leonardo Venture GmbH & Co. KGaA Leonardo Venture GmbH & Co.
KGaA is a holding company focusing on companies in the fields of
health and life quality in Germany and other German-speaking
countries. As an early-phase investor Leonardo Venture not only makes
available capital but also extensive know-how to its investments for
their business development.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Leonardo Venture GmbH & Co. KGaA
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Sandra Schwarz

Telefon: +49 (0)621 438 430 27

E-Mail: schwarz@leonardoventure.de

Branche: Financial & Business Services
ISIN: DE0005878763
WKN: 587876
Börsen: Börse Frankfurt / regulated dealing/prime standard